Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients
European Journal of Cancer, 04/05/2012BhooPathy N et al. –
Even though Adjuvant! Online is capable of discriminating between good and poor survivors, it systematically overestimates survival. These findings suggest that the model requires adaptation prior to use in Asian settings.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.